Stocks and Investing
Stocks and Investing
Thu, April 4, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Lewis Maintained (AHR) at Strong Buy with Decreased Target to $16 on, Apr 3rd, 2024
Michael Lewis of Truist Securities, Maintained "American Healthcare REIT, Inc." (AHR) at Strong Buy with Decreased Target from $17 to $16 on, Apr 3rd, 2024.
Michael has made no other calls on AHR in the last 4 months.
There are 6 other peers that have a rating on AHR. Out of the 6 peers that are also analyzing AHR, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Griffin of "Citigroup" Initiated at Hold and Held Target at $14 on, Monday, March 4th, 2024
These are the ratings of the 5 analyists that currently disagree with Michael
- Aaron Hecht of "JMP Securities" Reiterated at Buy and Held Target at $16 on, Monday, March 25th, 2024
- Anthony Powell of "Barclays" Initiated at Buy and Held Target at $18 on, Thursday, March 14th, 2024
- Austin Wurschmidt of "Keybanc" Initiated at Buy and Held Target at $16 on, Monday, March 4th, 2024
- Brian Cheng of "RBC Capital" Initiated at Buy and Held Target at $15 on, Monday, March 4th, 2024
- Ronald Kamdem of "Morgan Stanley" Initiated at Buy and Held Target at $17 on, Monday, March 4th, 2024
Contributing Sources